|
Sign In to gain access to subscriptions and/or personal tools.
|
Molecular Basis of Dioxin Actions: Evidence Supporting Chemoprotection
William F. Greenlee
CIIT, Research Triangle Park, North Carolina
Leslie J. Hushka
ExxonMobil Biomedical Sciences Inc, Annandale, New Jersey
Dennet R. Hushka
Huntingdon Life Sciences Inc, East Millstone, New Jersey
2,3,7,8-Tetrachlorodibenzo- p-dioxin (TCDD or dioxin), a highly publicized environmental contaminant, was shown to be chemoprotective against breast cancer in both rats and mice in bioassays conducted in the late 1970s. This fi nding went largely unnoticed as investigators focused on animal tumors that were increased by dioxin. The position that dioxin causes human tumors remains a subject for debate; however, recent epidemiological studies of a population highly exposed to dioxin in 1976 as a result of an industrial accident suggest that women with higher dioxin body burdens may have a lower incidence of breast cancer. With the growth of new knowledge about the molecular basis of dioxin actions in humans and animals, it is clear that most of the responses produced by this agent are initiated by a specifi c recognition protein (designated the Ah receptor) found in almost all animal and human tissues and organs. The recognition event between the Ah receptor and environmental agents like dioxin is due to the formation of a complex. We have observed that in the presence of dioxin, the Ah receptor turns off proliferation in tumor cells and suppresses the ability of these cells to invade normal tissue. We believe that these fi ndings provide a molecular and biochemical basis for understanding the chemoprotective mechanisms suggested by the fi ndings of rodent bioassays and could lead to the development of novel therapeutic agents targeting the Ah receptor.
Key Words: TCDD • Ah receptor • cell cycle regulation • chemoprotection • ligand switch • gene transcription
References
- Abbott B., Birnbaum L. (1989). TCDD alters medial epithelial cell differentiation during palatogenesis. Toxicol Appl Pharmacol 99: 276—286.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Abbott B., Birnbaum L., Perdew G. (1995). Developmental expression of two members of a new class of transcription factors: I. Expression of aryl hydrocarbon receptor in the C57BL/6N mouse embryo. Dev Dyn 204: 133—143.[Web of Science][Medline]
[Order article via Infotrieve]
- Bertazzi A., Pesatori A., Consonni D., Tironi A., Landi M., Zocchetti C. (1993). Cancer incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Epidemiology 4: 398 — 406.[Web of Science][Medline]
[Order article via Infotrieve]
- Bjeldanes L., Kim J., Grose K., Bartholomew J., Bradfield C. (1991). Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: Comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc Natl Acad Sci USA 88: 9543—9547.[Abstract/Free Full Text]
- Crews ST (1998). Control of cell lineage-specific development and transcription by bHLH-PAS proteins. Genes Dev 12: 607—620.[Free Full Text]
- Greenlee W., Sutter T., Marcus C. (1994). Molecular basis of dioxin actions on rodent and human target tissues. Prog Clin Biol Res 387:47—57.[Medline]
[Order article via Infotrieve]
- Hushka D., Greenlee WF (1995). 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits DNA synthesis in rat primary hepatocytes. Mutat Res 333: 89—99.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kafafi S., Afeefy H., Ali A., Said H., Abd-Elazem I., Kafafi A. (1993). Affinities for the aryl hydrocarbon receptor, potencies as aryl hydrocarbon hydroxylase inducers and relative toxicities of polychlorinated biphenyls: A congener specifi capproach. Carcinogenesis 14: 2063—2071.[Abstract/Free Full Text]
- Kociba R., Keyes D., Beyer J., Carreon R., Wade C., Dittenber D., Kalnins R., Frauson L., Park C., Barnard S., Hummel R., Humiston C. (1978). Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol 46: 279—303.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ma Q., Whitlock JPJr (1996). The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Mol Cell Biol 16: 2144—2150.[Abstract]
- Osborne R., Greenlee WF (1985). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) enhances terminal differentiation of cultured human epidermal cells. Toxicol Appl Pharmacol 77: 434 — 443.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Peters J., Wiley L. (1995). Evidence that murine preimplantation embryos express aryl hydrocarbon receptor. T oxicol Appl Phar-macol 134: 214—221.[CrossRef]
- Safe S., Astroff B., Harris M., Zacharewski T., Dickerson R., Romkes M., Biegel L. (1991). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds as antioestrogens. Characterization and mechanism of action. Pharmacol Toxicol 69: 400—409.[Web of Science][Medline]
[Order article via Infotrieve]
- Schmidt J., Bradfield C. (1996). AH receptor signaling pathways. Ann Rev Cell Dev Biol 12: 55—89.[CrossRef]
- Vanden Heuvel J, Lucier G. (1993). Environmental toxicology of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans. Environ Health Perspect 100: 189—200.[Web of Science][Medline]
[Order article via Infotrieve]
Toxicologic Pathology, Vol. 29, No. 1,
6-7 (2001)
DOI: 10.1080/019262301301418810
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
